99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between99mTc-MIBI uptake and P-alvcoprotein expression in tumour tissue
- 1 January 1996
- journal article
- case report
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (8) , 976-979
- https://doi.org/10.1007/bf01084374
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.1995
- Sequential functional imaging with technetium-99m hexakis-2-meth oxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?European Journal of Nuclear Medicine and Molecular Imaging, 1995
- Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?1993
- Isolation and Characterization of the Human MDR (P-Glycoprotein) GenesPublished by Springer Nature ,1991
- Immunohistochemical Analysis of P-Glycoprotein Expression in Normal and Tumor Tissues in HumansPublished by Springer Nature ,1991
- Expression of the Multidrug Resistance Gene in Human CancerPublished by Springer Nature ,1991
- Expression of the MDR1 Gene in Normal Human TissuesPublished by Springer Nature ,1991
- Noncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes.1990
- MDR1 RNA Levels in Human Renal Cell Carcinomas: Correlation With Grade and Prediction of Reversal of Doxorubicin Resistance by Quinidine in Tumor ExplantsJNCI Journal of the National Cancer Institute, 1989